Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombotic Therapy in Coronary Artery Ectasia
NCT03896321Completed
- Sponsor
- Assiut University
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin, clopidogrel and warfarin in Coronary artery ectasia (CAE) (3 arms), sponsored by Assiut University. Primary endpoints: Major Adverse Cardiovascular Events at 6 months and Major or Minor Bleeding at 6 months. Started Dec 2019; status: completed.
02
Drugs
aspirinclopidogrelwarfarin
03
Conditions
Coronary artery ectasia (CAE)
Beyond the preview
Go deeper on NCT03896321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03896321.